Montréal, Quebec, Canada GeneChem is the famous VC, which was founded in 1997. The venture was found in North America in Canada. The main office of represented VC is situated in the Montru00e9al.
The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cytochroma, LymphoSign, Osprey Pharmaceuticals USA. Among the most successful fund investment fields, there are Pharmaceutical, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2001. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this GeneChem works on 9 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013.
We also calculated 2 valuable employees in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the GeneChem, startups are often financed by Canadian Medical Discoveries Fund, VentureLink LP, The Still River Fund. The meaningful sponsors for the fund in investment in the same round are Canadian Medical Discoveries Fund, Gimv, Yasuda Enterprise Development. In the next rounds fund is usually obtained by Novo Holdings, VenGrowth Asset Management, VentureLink LP.
| Fund Name | Location |
| Changzhou Investment Group Co Ltd | Changzhou, China, Zhejiang |
| E-House | China, Shanghai |
| Eclosion SA | Geneva, Geneve, Switzerland |
| GenenFUND | - |
| Highgrowth Partners | Barcelona, Catalonia, Spain |
| Huoban Chuangtou | Beijing, China, Haidian |
| IFM Investors | Australia, Melbourne, Victoria |
| KCA INVESTMENT | China, Dalian, Zhejiang |
| KP Partners | - |
| LinkMe Mobile | - |
| Lonyer Holding | - |
| NEC Electronics America | - |
| People Combine | Andhra Pradesh, Hyderabad, India |
| Savoie Angels | France, Le Bourget-du-lac, Rhone-Alpes |
| Seaya Ventures | Madrid, Madrid, Spain |
| Slack Fund | California, Daly City, United States |
| Synergo Capital | Italy, Lombardy, Milan |
| Tree Line Asia | China, Hong Kong, Hong Kong Island |
| Vira Ventures | Argentina, Buenos Aires, Distrito Federal |
| Yahui Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Idun Pharmaceuticals | $22M | 09 Dec 2002 | San Diego, California, United States | ||
Avalon Pharmaceuticals | $70M | 17 Dec 2001 | Germantown, Maryland, United States | ||
Viron Therapeutics | $7M | 19 Jan 2000 | London, Ontario, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Idun Pharmaceuticals | $22M | 09 Dec 2002 | San Diego, California, United States | ||
Avalon Pharmaceuticals | $70M | 17 Dec 2001 | Germantown, Maryland, United States | ||
Viron Therapeutics | $7M | 19 Jan 2000 | London, Ontario, Canada |
